← Leaderboards
Matthew J Lavoie
Brigham And Women'S Hospital
$9,400,899
Attributed
$9,400,899
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,400,899 · 7
By mechanism
R01$7,229,017 · 3
R21$1,415,542 · 3
K01$756,340 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Jie Shen$46,115,873
- Ulf Dettmer$4,942,215
- Nagendran Ramalingam$2,996,571
- Michael G Schlossmacher$2,489,568
- Peter T Lansbury$7,464,017
Others in their field
Top investigators on “Parkinson Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson DiseaseProteinsNeuronsPlayInsightNeurodegenerative DisordersAffectPathogenesisBiologyReportingLinkPathway InteractionsRegulationGenesCollaborationsSynucleinBiochemicalIn VitroCellsMutantMutationNervous System DisorderPhosphotransferasesInterest
Grant awards (32)
Intersection of GBA and LRRK2 in Lewy Body Dementia$566,785
R01 · FY2025 · AG · contact PI
Intersection of GBA and LRRK2 in Lewy Body Dementia$560,489
R01 · FY2024 · AG · contact PI
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE$351,213
R01 · FY2022 · NS · contact PI
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE$351,213
R01 · FY2021 · NS · contact PI
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE$351,213
R01 · FY2020 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$333,594
R01 · FY2020 · NS · contact PI
Pathologic LRRK2 signaling in Familial and Idiopathic Parkinson's Disease$450,195
R01 · FY2019 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$345,496
R01 · FY2019 · NS · contact PI
Pathologic LRRK2 signaling in Familial and Idiopathic Parkinson's Disease$297,515
R01 · FY2019 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$42,785
R01 · FY2019 · NS · contact PI
Pathologic LRRK2 signaling in Familial and Idiopathic Parkinson's Disease$470,654
R01 · FY2018 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$388,281
R01 · FY2018 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$388,281
R01 · FY2017 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$388,281
R01 · FY2016 · NS · contact PI
The Activation of LRRK2 by Alpha-Synuclein$259,990
R21 · FY2015 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$378,832
R01 · FY2014 · NS · contact PI
The Activation of LRRK2 by Alpha-Synuclein$215,042
R21 · FY2014 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$369,267
R01 · FY2013 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$382,659
R01 · FY2012 · NS · contact PI
Regulation of Leucine Rich Repeat Kinase 2 (LRRK2)$223,125
R21 · FY2012 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$50,829
R01 · FY2012 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$377,178
R01 · FY2011 · NS · contact PI
Regulation of Leucine Rich Repeat Kinase 2 (LRRK2)$267,563
R21 · FY2011 · NS · contact PI
Genetic Models to Probe the Role of Complex-1 Dysfunction in Neurologic Disease$239,022
R21 · FY2011 · NS · contact PI
Role of Parkin in Familial and Idiopathic Parkinson's Disease$384,257
R01 · FY2010 · NS · contact PI
Genetic Models to Probe the Role of Complex-1 Dysfunction in Neurologic Disease$210,800
R21 · FY2010 · NS · contact PI
Protein Aggregation and Modification in Neurodegeneration$129,668
K01 · FY2010 · AG · contact PI
Protein Aggregation and Modification in Neurodegeneration$129,668
K01 · FY2009 · AG · contact PI
Protein Aggregation and Modification in Neurodegeneration$108,000
K01 · FY2009 · AG · contact PI
Protein Aggregation and Modification in Neurodegeneration$129,668
K01 · FY2008 · AG · contact PI
Protein Aggregation and Modification in Neurodegeneration$129,668
K01 · FY2007 · AG · contact PI
Protein Aggregation & Modification in Neurodegeneration$129,668
K01 · FY2006 · AG · contact PI